Clinical Trial Update: Lignosus Rhinoceros TM02® as a Complementary Therapy for Uncontrolled Asthma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Lignosus Rhinoceros TM02 as a complementary therapy for uncontrolled asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Lignosus Rhinoceros TM02

Snippet

Sponsor: University of Malaya | Conditions: Asthma | Phase 2 | Status: COMPLETED